Most patients (83%) had invasive ductal carcinoma; half had a primary tumor >20 mm in size (pT2); 27% had grade 3 tumors, 90% a Ki67 level >20%, and 40% a PgR expression ≤20% (Table 1). This evidence concerns the gene PGR and invasive ductal breast carcinoma.